Multi-kinase-IN-12

Overview

Multi-kinase-IN-12 is a non-selective multi-target inhibitor, with IC 50 values against human targets as follows: Flt3 < 0.001 μM, c-Src 0.002 μM, KDR 0.004 μM, Eph-A2 , MNK-1 and Flt1 0.011 μM, Lck 0.016 μM, Rsk1 0.21 μM, and α2 subunit of AMPK 0.041 μM. Multi-kinase-IN-12 can be used in research related to solid tumors.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Ephrin Receptor | Products > Signaling Pathways > MNK | Products > Signaling Pathways > Ribosomal S6 Kinase (RSK) | Products > Signaling Pathways > AMPK | Products > Signaling Pathways > FLT3 | Products > Signaling Pathways > Src | Products > Signaling Pathways > VEGFR

Product Information

• Catalog No.: HY-18692
• CAS No.: 597544-21-3
• Molecular Formula: C23H23N5O2
• Molecular Weight: 401.47
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source